Infections due to various atypical mycobacteria in a Norwegian multiplex family with dominant interferon-γ receptor deficiency

Clinical Infectious Diseases

Volumn 46, Issue 3, 2008, Pages

  Glosli, Heidi ^a   Stray Pedersen, Asbjørg ^a   Brun, Anne C ^c   Holtmon, Lena W ^c   Tønjum, Tone ^a,b   Chapgier, Ariadne ^d   Casanova, Jean L ^d,e   Abrahamsen, Tore G ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c VESTFOLD HOSPITAL TRUST   (Norway)

^d INSERM   (France)

^e HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOSALICYLIC ACID; BCG VACCINE; CEFOTAXIME; CIPROFLOXACIN; CLARITHROMYCIN; ETHAMBUTOL; GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR 1; ISONIAZID; LINEZOLID; PENICILLIN G; PROTIONAMIDE; PYRAZINAMIDE; RIFABUTIN; RIFAMPICIN; SALBUTAMOL; STREPTOMYCIN; TUBERCULOSTATIC AGENT; VANCOMYCIN;

ADOLESCENT; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIAL INFECTION; BACTERIUM CULTURE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNE DEFICIENCY; INTERFERON GAMMA RECEPTOR 1 DEFICIENCY; LIVER ABSCESS; LUNG ABSCESS; MALE; MYCOBACTERIUM; MYCOBACTERIUM BOVIS; MYCOBACTERIUM GORDONAE; MYCOBACTERIUM INTRACELLULARE AVIUM; MYCOBACTERIUM SCROFULACEUM; NORWAY; OSTEOMYELITIS; PRIORITY JOURNAL; PUS; TREATMENT OUTCOME;

EID: 39349116765     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/525855     Document Type: Article

References (25)

1. Darnell JE Jr, Kerr IM, Stark GR. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994; 264:1415-21.
2. Newport MJ, Huxley CM, Huston S, et al. A mutation in the interferon-γ-receptor gene and susceptibility to mycobacterial infection. N Engl J Med 1996; 335:1941-9.
3. Jouanguy E, Altare F, Lamhamedi S, et al. Interferon-γ-receptor deficiency in an infant with fatal bacille Calmette-Guérin infection. N Engl J Med 1996; 335:1956-61.
4. Jouanguy E, Dupuis S, Pallier A, et al. In a novel form of IFN-γ receptor 1 deficiency, cell surface receptors fail to bind IFN-γ. J Clin Invest 2000; 105:1429-36.
5. Jouanguy E, Lamhamedi-Cherradi S, Lammas D, et al. A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection. Nat Genet 1999; 21:370-8.
6. Casanova JL. Mendelian susceptibility to mycobacterial infection in man. Swiss Med Wkly 2001; 131:445-54.
7. Dupuis S, Döffinger R, Picard C, et al. Human interferon-γ- mediated immunity is a genetically controlled continuous trait that determines the outcome of mycobacterial invasion. Immunol Rev 2000; 178:129-37.
8. Feinberg J, Fieschi C, Doffinger R, et al. Bacillus Calmette Guérin triggers the IL-12/IFN-γ axis by an IRAK-4- and NEMO-dependent, non-cognate interaction between monocytes, NK, and T lymphocytes. Eur J Immunol 2004; 34:3276-84.
9. Solheim LF, Kjelsberg F. Recurrent mycobacterial osteomyelitis. Report of a case due to Mycobacterium avium-intracellulare-scrofulaceum complex and BCG vaccination. Arch Orthop Trauma Surg 1982; 100:277-80.
10. Dorman SE, Picard C, Lammas D, et al. Clinical features of dominant and recessive interferon g receptor 1 deficiencies. Lancet 2004; 364:2113-21.
11. Filipe-Santos O, Bustamante J, Chapgier A, et al. Inborn errors of IL-12/23- and IFN-γ-mediated immunity: molecular, cellular, and clinical features. Semin Immunol 2006; 18:347-61.
12. Casanova JL, Abel L. Genetic dissection of immunity to mycobacteria: the human model. Annu Rev Immunol 2002; 20:581-620.
13. Sasaki Y, Nomura A, Kusuhara K, et al. Genetic basis of patients with bacille Calmette-Guérin osteomyelitis in Japan: identification of dominant partial interferon-γ receptor 1 deficiency as a predominant type. J Infect Dis 2002; 185:706-9.
14. Han JY, Rosenzweig SD, Church JA, et al. Variable presentation of disseminated nontuberculous mycobacterial infections in a family with an interferon-γ receptor mutation. Clin Infect Dis 2004; 39:868-70.
15. Doffinger R, Patel SY, Kumararatne DS. Host genetic factors and mycobacterial infections: lessons from single gene disorders affecting innate and adaptive immunity. Microbes Infect 2006; 8:1141-50.
16. Arend SM, Janssen R, Gosen JJ, et al. Multifocal osteomyelitis caused by nontuberculous mycobacteria in patients with a genetic defect of the interferon-γ receptor. Neth J Med 2001; 59:140-51.
17. Villella A, Picard C, Jouanguy E, et al. Recurrent Mycobacterium avium osteomyelitis associated with a novel dominant interferon gamma receptor mutation. Pediatrics 2001; 107:E47.
18. Dorman SE, Uzel G, Roesler J, et al. Viral infections in interferon-γ receptor deficiency. J Pediatr 1999; 135:640-3.
19. Zerbe CS, Holland SM. Disseminated histoplasmosis in persons with interferon-γ receptor 1 deficiency. Clin Infect Dis 2005; 41:e38-41.
20. Smyth AE, Jackson P, Lammas D, et al. Differential response to interferon-γ therapy in a family with dominant negative partial interferon-γ receptor1 deficiency. Eur J Pediatr 2006; 165:71-2.
21. Ehlers S, Richter E. Differential requirement for interferon-γ to restrict the growth of or eliminate some recently identified species of non-tuberculous mycobacteria in vivo. Clin Exp Immunol 2001; 124:229-38.
22. Wolinsky E. Mycobacterial lymphadenitis in children - a prospective study of 105 nontuberculous cases with long-term follow-up. Clin Infect Dis 1995; 20:954-63.
23. Reischl U, Emler S, Horak Z, et al. Mycobacterium bohemicum sp. nov., a new slow-growing scotochromogenic mycobacterium. Int J Syst Bacteriol 1998; 48:1349-55.
24. Tortoli E, Bartoloni A, Manfrin V, et al. Cervical lymphadenitis due to Mycobacterium bohemicum. Clin Infect Dis 2000; 30:210-1.
25. Palca A, Aebi C, Weimann R, et al. Mycobacterium bohemicum cervical lymphadenitis. Pediatr Infect Dis J 2002; 21:982-4.